Deutsche Bank Ag\ Talis Biomedical Corp Transaction History

Deutsche Bank Ag\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.54 $6,523 - $8,006	-14,826 Reduced 24.66%	45,294 $21,000
Q2 2022 Aug 11, 2022	BUY	$0.81 - $1.44 $42,347 - $75,284	52,281 Added 666.93%	60,120 $49,000
Q1 2022 May 13, 2022	SELL	$1.3 - $4.19 $1,224 - $3,946	-942 Reduced 10.73%	7,839 $11,000
Q4 2021 Feb 11, 2022	SELL	$3.81 - $6.17 $23,721 - $38,414	-6,226 Reduced 41.49%	8,781 $35,000
Q3 2021 Nov 04, 2021	BUY	$6.02 - $12.46 $41,748 - $86,410	6,935 Added 85.91%	15,007 $94,000
Q2 2021 Aug 11, 2021	SELL	$9.62 - $14.56 $2,568 - $3,887	-267 Reduced 3.2%	8,072 $89,000
Q1 2021 May 13, 2021	BUY	$11.2 - $27.8 $93,396 - $231,824	8,339 New	8,339 $107,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.